l-carnitine and atherosclerosis Metabolite acetyl-L-carnitine participates in Bifidobacterium animalis F1-7 to ameliorate atherosclerotic inflammation by downregulating theTLR4/NF-κB pathway Dietary precursors, such as choline

Graphical Abstract Similar content being viewed by others Introduction Tumor immunotherapy represents a significant advancement in cancer treatment in recent years [1,2,3]

Maintenance dose optimization Once reaching the initial target dose, assessment determines whether further increases benefit the protocol

The increasing reliance of adolescents on vitamin D for calcium homeostasis and the detrimental effects of inadequate sun exposure or obesity-related vitamin D deficiency on bone mineral density are being acknowledged as significant public health concerns

The oral formulation is the most significant differentiator: if an oral tablet can produce weight loss comparable to injectable CagriSema, it could fundamentally change how dual pathway obesity therapy is delivered

The biochemistry of P-glycoprotein-mediated multidrug resistance